Dinglan Zuo

812 total citations
25 papers, 534 citations indexed

About

Dinglan Zuo is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Dinglan Zuo has authored 25 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Hepatology. Recurrent topics in Dinglan Zuo's work include RNA modifications and cancer (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dinglan Zuo is often cited by papers focused on RNA modifications and cancer (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dinglan Zuo collaborates with scholars based in China, Hong Kong and United States. Dinglan Zuo's co-authors include Yunfei Yuan, Wei He, Jiliang Qiu, Binkui Li, Chenwei Wang, Yuanping Zhang, Wenwu Liu, Zhiwen Yang, Yadi Liao and Yichuan Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Oncogene.

In The Last Decade

Dinglan Zuo

24 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dinglan Zuo China 14 249 193 187 130 100 25 534
Irene Lo China 7 198 0.8× 142 0.7× 100 0.5× 101 0.8× 147 1.5× 9 467
Keshuai Dong China 14 193 0.8× 133 0.7× 102 0.5× 68 0.5× 131 1.3× 26 418
Poh Seng Tan Singapore 12 156 0.6× 124 0.6× 259 1.4× 166 1.3× 67 0.7× 26 541
Wenli Sai China 12 202 0.8× 151 0.8× 90 0.5× 80 0.6× 107 1.1× 32 366
Binghua Dai China 16 397 1.6× 327 1.7× 77 0.4× 106 0.8× 127 1.3× 30 624
Yunxing Shi China 10 178 0.7× 123 0.6× 145 0.8× 56 0.4× 68 0.7× 17 386
Tsung‐Hui Hu Taiwan 8 271 1.1× 107 0.6× 242 1.3× 170 1.3× 104 1.0× 12 566
Lun Qin China 6 267 1.1× 242 1.3× 127 0.7× 76 0.6× 117 1.2× 7 532
Marzia Galassi Italy 8 225 0.9× 234 1.2× 185 1.0× 133 1.0× 70 0.7× 9 534
Xueyong Zheng China 12 378 1.5× 287 1.5× 103 0.6× 55 0.4× 158 1.6× 35 682

Countries citing papers authored by Dinglan Zuo

Since Specialization
Citations

This map shows the geographic impact of Dinglan Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinglan Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinglan Zuo more than expected).

Fields of papers citing papers by Dinglan Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinglan Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinglan Zuo. The network helps show where Dinglan Zuo may publish in the future.

Co-authorship network of co-authors of Dinglan Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Dinglan Zuo. A scholar is included among the top collaborators of Dinglan Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinglan Zuo. Dinglan Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Yichuan, Yunxing Shi, Lin Zhu, et al.. (2025). USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 122(38). e2510576122–e2510576122.
2.
Shi, Yunxing, Kai Li, Yichuan Yuan, et al.. (2024). Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma. Cancer Cell International. 24(1). 138–138. 2 indexed citations
3.
Shi, Yunxing, Dinglan Zuo, Yi Niu, et al.. (2024). Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling. Nature Communications. 15(1). 7930–7930. 19 indexed citations
4.
Wang, Yongjin, Dinglan Zuo, Yi Zeng, et al.. (2024). KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis. International Journal of Molecular Sciences. 25(13). 7165–7165. 3 indexed citations
5.
Guo, Lingling, Zhijie Liu, Dinglan Zuo, et al.. (2024). Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/− mice. iScience. 27(7). 110205–110205. 3 indexed citations
6.
Zhu, Lin, Jiliang Qiu, Dinglan Zuo, et al.. (2024). m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 206–206. 8 indexed citations
7.
Bi, Fangfang, et al.. (2023). METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition. Cell Death Discovery. 9(1). 428–428. 13 indexed citations
8.
Li, Kai, Zhiyu Qiu, Yichuan Yuan, et al.. (2023). Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
9.
Shi, Yunxing, Yi Niu, Yichuan Yuan, et al.. (2023). PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer. Nature Communications. 14(1). 1932–1932. 50 indexed citations
10.
Qiu, Zhiyu, Chenwei Wang, Pinzhu Huang, et al.. (2023). RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1. Clinical and Translational Medicine. 13(12). e1511–e1511. 14 indexed citations
11.
Li, Kai, Yi Niu, Yichuan Yuan, et al.. (2022). Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene. 41(23). 3197–3209. 13 indexed citations
12.
Zhang, Yuanping, Dinglan Zuo, Jiliang Qiu, et al.. (2022). NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3. Cell Death and Disease. 13(8). 676–676. 2 indexed citations
13.
Wang, Chenwei, Yadi Liao, Wei He, et al.. (2021). Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 113–113. 26 indexed citations
14.
Wang, Yongjin, Yadi Liao, Wenwu Liu, et al.. (2020). Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy. Digestive Surgery. 38(1). 46–57. 1 indexed citations
15.
Liao, Yadi, Chenwei Wang, Zhiwen Yang, et al.. (2020). Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma. Theranostics. 10(12). 5209–5224. 66 indexed citations
16.
Liu, Wenwu, Ruhai Zou, Chenwei Wang, et al.. (2019). Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis. Therapeutic Advances in Medical Oncology. 11. 3862489692–3862489692. 27 indexed citations
17.
Yang, Zhiwen, Ruhai Zou, Yun Zheng, et al.. (2019). Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation. European Radiology. 29(11). 5752–5762. 28 indexed citations
18.
Liu, Wenwu, Zhiwen Yang, Ruhai Zou, et al.. (2019). Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study. Journal of Cancer. 10(13). 2857–2867. 7 indexed citations
19.
Wang, Chenwei, Wei He, Yichuan Yuan, et al.. (2019). Comparison of the prognostic value of inflammation‐based scores in early recurrent hepatocellular carcinoma after hepatectomy. Liver International. 40(1). 229–239. 51 indexed citations
20.
Li, Binkui, Liru He, Dinglan Zuo, et al.. (2017). Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. Journal of Cancer. 8(6). 940–949. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Lo Breakdown of academic impact, for papers by Keshuai Dong Breakdown of academic impact, for papers by Poh Seng Tan Breakdown of academic impact, for papers by Wenli Sai Breakdown of academic impact, for papers by Binghua Dai Breakdown of academic impact, for papers by Yunxing Shi Breakdown of academic impact, for papers by Tsung‐Hui Hu Breakdown of academic impact, for papers by Lun Qin Breakdown of academic impact, for papers by Marzia Galassi Breakdown of academic impact, for papers by Xueyong Zheng
Rankless by CCL
2026